Ovensa and Celanese Explore Collaborative Innovation to Advance Precision Drug Delivery and Therapeutic Outcomes
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 05:30 PM Eastern Daylight Time AURORA, Ontario & DALLAS--(BUSINESS WIRE)--Ovensa Inc. ('Ovensa'), a company enabling the development of targeted therapies and delivery systems using proprietary nanoparticle compositions, and Celanese Corporation, a global chemical and specialty materials company, today announced plans to collaborate on the long-acting controlled release of targeted therapeutics that address current performance, toxicity and resistance challenges in the market.

The companies will evaluate the synergy of Celanese's VitalDose® EVA copolymer delivery technology for drug-eluting implants and Ovensa's TRIOZAN™ Platform for enhanced RNA, mAb and peptide-based molecule drug delivery.
